Back to NTLA

Intellia Therapeutics, Inc. 8-K

Accession 0001193125-20-156459

Filing information

CIK
0001652130
Report date
2020-05-30
Filing date
2020-06-01
Form
8-K
Primary document
d830395d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.